Effectiveness of the Autologous Blood Patch Method in Lung Biopsies

Inclusion Criteria:

* Patients older than 18 years
* Patients who underwent percutaneous transthoracic tru cut biopsy
* Patients undergoing interventional procedures by radiologists with equal experience
* Patients who were able to obtain sufficient samples with the applied biopsy (technical success of percutaneous transthoracic biopsy)
* Patients whose medical records are fully accessible and whose data are reliable

Exclusion Criteria:

* Patients whose laboratory bleeding parameters are not suitable for the procedure (platelets\<100000/mm3, INR\>1.5)
* Pregnancy
* Patients with increased risk of pneumothorax due to other etiologies (bulla, blep, chronic obstructive pulmonary disease, cystic fibrosis)
* Patients receiving anticoagulant antiplatelet therapy
* Patients with persistent cough
* Patients with a history of recent lung travma, pneumothorax, hemoptysis or pulmonary hemorrhage
* Patients with severe psychiatric diseases such as psychosis or dementia that limit cooperation with the patient
* Patients with anatomic deformity (advanced scoliosis and kyphotic patients. Patients with pectus carinatum and pectus excavatum-like chest deformity)
* Patients for whom tru cut biopsy is absolutely and relative contraindicated (suspected hydatid cyst or known vascular lesions such as arteriovenous malformation, pulmonary varicose, severe obstructive pulmonary disease, coagulopathy, moderate to severe pulmonary hypertension, ventilator dependence, unilateral pneumectomy)
* Patients allergic to local anesthetic drug used for skin and subcutaneous tissue anesthesia
* Patients who do not want to participate